Unknown

Dataset Information

0

Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn's Disease.


ABSTRACT:

Background and aims

Cannabinoid receptor stimulation may have positive symptomatic effects on inflammatory bowel disease [IBD] patients through analgesic and anti-inflammatory effects. The cannabinoid 2 receptor [CB2R] is expressed primarily on immune cells, including CD4+ T cells, and is induced by active inflammation in both humans and mice. We therefore investigated the effect of targeting CB2R in a preclinical IBD model.

Methods

Employing a chronic ileitis model [TNF?ARE/+ mice], we assessed expression of the CB2R receptor in ileal tissue and on CD4+ T cells and evaluated the effect of stimulation with CB2R-selective ligand GP-1a both in vitro and in vivo. Additionally, we compared cannabinoid receptor expression in the ilea and colons of healthy human controls with that of Crohn's disease patients.

Results

Ileal expression of CB2R and the endocannabinoid anandamide [AEA] was increased in actively inflamed TNF?ARE/+ mice compared with controls. CB2R mRNA was preferentially induced on regulatory T cells [Tregs] compared with T effector cells, approximately 2.4-fold in wild-type [WT] and 11-fold in TNF?ARE/+ mice. Furthermore, GP-1a enhanced Treg suppressive function with a concomitant increase in IL-10 secretion. GP-1a attenuated murine ileitis, as demonstrated by improved histological scoring and decreased inflammatory cytokine expression. Lastly, CB2R is downregulated in both chronically inflamed TNF?ARE/+ mice and in IBD patients.

Conclusions

In summary, the endocannabinoid system is induced in murine ileitis but is downregulated in chronic murine and human intestinal inflammation, and CB2R activation attenuates murine ileitis, establishing an anti-inflammatory role of the endocannabinoid system.

SUBMITTER: Leinwand KL 

PROVIDER: S-EPMC5881726 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background and aims</h4>Cannabinoid receptor stimulation may have positive symptomatic effects on inflammatory bowel disease [IBD] patients through analgesic and anti-inflammatory effects. The cannabinoid 2 receptor [CB2R] is expressed primarily on immune cells, including CD4+ T cells, and is induced by active inflammation in both humans and mice. We therefore investigated the effect of targeting CB2R in a preclinical IBD model.<h4>Methods</h4>Employing a chronic ileitis model [TNFΔARE/+ mic  ...[more]

Similar Datasets

| S-EPMC6290787 | biostudies-literature
| S-EPMC3404971 | biostudies-literature
| S-EPMC7017073 | biostudies-literature
| S-EPMC4793079 | biostudies-literature
| S-EPMC6056551 | biostudies-literature
| S-EPMC3044199 | biostudies-literature
| S-EPMC3606708 | biostudies-literature
| S-EPMC4817310 | biostudies-literature
| S-EPMC7224120 | biostudies-literature
2017-01-09 | GSE60903 | GEO